Published in Am J Physiol Cell Physiol on March 12, 2008
Knockdown of transient receptor potential canonical-1 reduces the proliferation and migration of endothelial progenitor cells. Stem Cells Dev (2011) 0.96
FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway. J Biol Chem (2013) 0.88
Pathophysiological roles of FGF signaling in the heart. Front Physiol (2013) 0.87
Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells. J Neuropathol Exp Neurol (2010) 0.87
Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16. Genes Cells (2013) 0.86
Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury. Physiol Rep (2015) 0.81
FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart. Cardiovasc Res (2010) 0.79
Identification of three novel FGF16 mutations in X-linked recessive fusion of the fourth and fifth metacarpals and possible correlation with heart disease. Mol Genet Genomic Med (2014) 0.78
PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes. Br J Pharmacol (2014) 0.76
Fgf16 is required for specification of GABAergic neurons and oligodendrocytes in the zebrafish forebrain. PLoS One (2014) 0.75
The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48
Biological roles of oligosaccharides: all of the theories are correct. Glycobiology (1993) 12.38
Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 7.58
Fibroblast growth factors. Genome Biol (2001) 7.32
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem (2006) 5.78
Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol (1996) 4.11
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 3.88
Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell (2005) 2.93
Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev (2006) 2.56
The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol Chem (1985) 2.27
Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res (2003) 2.26
Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest (2007) 2.12
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene (2005) 1.61
Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol (1999) 1.61
FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun (2000) 1.49
Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res (2003) 1.46
Human cyclin F. EMBO J (1994) 1.39
Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol (2006) 1.34
Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction. EMBO J (2000) 1.33
Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes. J Biol Chem (2000) 1.32
Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci (2004) 1.31
Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem Biophys Res Commun (1998) 1.28
Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol (2007) 1.21
Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy. J Mol Cell Cardiol (2001) 1.18
The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res (2000) 1.18
Biosynthesis of human fibroblast growth factor-5. Mol Cell Biol (1991) 1.09
Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol Heart Circ Physiol (2001) 1.06
Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ Res (1992) 1.01
Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. Cell Signal (2005) 0.97
Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun (2006) 0.97
Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochem J (2004) 0.96
Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am J Physiol (1995) 0.95
Fgf16 is essential for pectoral fin bud formation in zebrafish. Biochem Biophys Res Commun (2006) 0.95
Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. Oncogene (1993) 0.93
A hydrophobic region locating at the center of fibroblast growth factor-9 is crucial for its secretion. J Biol Chem (1999) 0.92
Secretion of FGF-16 requires an uncleaved bipartite signal sequence. J Biol Chem (2003) 0.90
Extracellular regulated kinase, but not protein kinase C, is an antiapoptotic signal of insulin-like growth factor-1 on cultured cardiac myocytes. Biochem Biophys Res Commun (2000) 0.89
alpha1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. Am J Physiol (1999) 0.88
FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J Mol Cell Cardiol (1998) 0.83
Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc Res (1999) 0.82
PKC-dependent phosphorylation may regulate the ability of connexin43 to inhibit DNA synthesis. Cell Commun Adhes (2003) 0.81
The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest. Exp Cell Res (1998) 0.80
Expression of fibroblast growth factor receptor-1 in rat heart H9c2 myoblasts increases cell proliferation. Mol Cell Biochem (1997) 0.79
Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity. J Cell Biol (1993) 0.79
Evaluation of alternative counting methods for radioimmunoassay of hepatitis-associated antigen (HB-Ag). Clin Chem (1974) 0.77
Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome. Am J Hum Genet (2009) 1.78
Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res (2003) 1.46
Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci (2004) 1.31
Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice. DNA Cell Biol (2010) 1.22
FGF-16 is required for embryonic heart development. Biochem Biophys Res Commun (2008) 1.08
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A (2002) 1.06
Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev (2007) 1.03
Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc Res (2004) 0.94
High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol (2006) 0.93
Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc Res (2004) 0.93
Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am J Physiol Heart Circ Physiol (2002) 0.92
Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol (2002) 0.92
Hepatocyte nuclear factor-3alpha binding at P sequences of the human growth hormone locus is associated with pituitary repressor function. Mol Endocrinol (2005) 0.86
Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. J Cell Physiol (2007) 0.84
RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin. Mol Endocrinol (2003) 0.83
FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction. Cardiovasc Toxicol (2013) 0.83
Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2. Can J Physiol Pharmacol (2004) 0.83
Cloning and bacterial expression of postnatal mouse heart FGF-16. Mol Cell Biochem (2003) 0.83
Binding of AP-2 and ETS-domain family members is associated with enhancer activity in the hypersensitive site III region of the human growth hormone/chorionic somatomammotropin locus. Mol Endocrinol (2003) 0.82
Transgenic mice expressing the human growth hormone gene provide a model system to study human growth hormone synthesis and secretion in non-tumor-derived pituitary cells: differential effects of dexamethasone and thyroid hormone. Mol Cell Endocrinol (2011) 0.81
FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters. Cardiovasc Res (2013) 0.81
Appearance of the pituitary factor Pit-1 increases chromatin remodeling at hypersensitive site III in the human GH locus. J Mol Endocrinol (2010) 0.80
FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart. Cardiovasc Res (2010) 0.79
Regulation of the human growth hormone gene family: possible role for Pit-1 in early stages of pituitary-specific expression and repression. Neuroendocrinology (2006) 0.79
Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region. DNA Cell Biol (2011) 0.79
Inhibition of TGFbeta signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis. Cardiovasc Res (2004) 0.79
The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells. Mol Cell Endocrinol (2012) 0.78
A myocyte enhancer factor 2 (MEF2) site located in a hypersensitive region of the FGF16 gene locus is required for preferential promoter activity in neonatal cardiac myocytes. DNA Cell Biol (2008) 0.78
CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity. J Biol Chem (2013) 0.78
Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells. J Biol Chem (2012) 0.78
Energy homeostasis targets chromosomal reconfiguration of the human GH1 locus. J Clin Invest (2014) 0.77
Identification of functional CCAAT/enhancer-binding protein and Ets protein binding sites in the human chorionic somatomammotropin enhancer sequences. J Mol Endocrinol (2011) 0.76
A single bout of exercise promotes sustained left ventricular function improvement after isoproterenol-induced injury in mice. J Physiol Sci (2011) 0.76
Protection by endogenous FGF-2 against isoproterenol-induced cardiac dysfunction is attenuated by cyclosporine A. Mol Cell Biochem (2011) 0.75
High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death. Mol Cell Biochem (2003) 0.75